ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $76 | -81.2% | 21,560 | -64.5% | 0.00% | -100.0% |
Q3 2023 | $405 | +195.6% | 60,649 | +339.5% | 0.00% | +300.0% |
Q1 2023 | $137 | -99.9% | 13,800 | -59.0% | 0.00% | -50.0% |
Q3 2022 | $180,000 | +100.0% | 33,685 | +49.7% | 0.00% | +100.0% |
Q2 2022 | $90,000 | +1.1% | 22,495 | +11.7% | 0.00% | 0.0% |
Q1 2022 | $89,000 | -11.0% | 20,131 | -19.6% | 0.00% | 0.0% |
Q4 2021 | $100,000 | -62.7% | 25,031 | -17.9% | 0.00% | -75.0% |
Q3 2021 | $268,000 | -85.6% | 30,494 | -80.5% | 0.00% | -85.2% |
Q1 2021 | $1,858,000 | +94.1% | 156,414 | +12.1% | 0.03% | +200.0% |
Q4 2020 | $957,000 | +1025.9% | 139,520 | +1121.5% | 0.01% | +350.0% |
Q3 2020 | $85,000 | +54.5% | 11,422 | -12.7% | 0.00% | +100.0% |
Q2 2020 | $55,000 | – | 13,085 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |